Last week, researchers dropped a bombshell report on DFNZ, a developing new medicine derived from a class of drugs once considered too dangerous to even study.
Their proposal sounded almost too good to be true: The drug might offer patients with chronic pain and injuries the benefits of an opioid without the threat of addiction or withdrawal.
In a thorough study of the effects of DFNZ on rats, the researchers observed that the drug had an obvious “reward” effect on the subjects, but at a certain point, the rodents easily stopped going back for more
The findings are especially timely, as Americans battle two crises that often overlap: chronic pain and opioid addiction. A 2018 scientific paper published in the Annual Review of Pharmacology and Toxicology found that more than 125 million Americans live with acute or chronic pain.
Bring it on!